Zelira Therapeutics Chairman Osagie Imasogie and Global CEO Dr Oludare Odumosu deliver a slide presentation and answer investor questions as part of a business update.

Zelira product helping young patient with autism spectrum disorder

Zelira AGM Presentation January 2022

CEO Oludare Odumosu and Chairman Osagie Imasogie presentation at the Zelira AGM 2022

Zelira AGM Presentation January 2022

A Global Biopharmaceutical Company Developing and Marketing Clinically Validated Cannabinoid-Based Medicines

Zelira Therapeutics’ commercialisation program

Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive

Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain

Zelira Chairman, Osagie Imasogie and CEO Oludare Odumosu

Zelira Chairman Presentation at Cantor Fitzgerald International Cannabis Forum

Zelira Therapeutics are well positioned for ‘multiple product launches in 2021’

Start typing and press Enter to search

Shopping Cart